In one experiment on female rats, Olanzapine might cause insulin-resistant PCOS by regulating the IGF1/p-AKT/FOXO1 and NF-KB/IL-1β/TNF-α signaling pathways (32). This evidence concerns the gene AKT1 and polycystic ovary syndrome.